Notes - Segment Information

Solasia Pharma K.K. - Filing #7272454

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
Notes - Segment information
Segment information
Revenue
Revenue
316,000,000 JPY
617,000,000 JPY
Share of profit (loss) of investments accounted for using equity method
-4,000,000 JPY
-5,000,000 JPY
Profit (loss) before tax
-1,961,000,000 JPY
-1,135,000,000 JPY
Assets
1,362,000,000 JPY
2,229,000,000 JPY
Investments accounted for using equity method
1,000,000 JPY
6,000,000 JPY
Depreciation and amortization
195,000,000 JPY
500,000,000 JPY
Impairment losses
959,000,000 JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.